查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529810

经皮皮肤贴片市场规模、份额和趋势分析报告：按类型、按应用、按分销管道、按地区和细分市场预测，2024-2030

Transdermal Skin Patches Market Size, Share & Trends Analysis Report By Type (Multi-layer Drug-in-Adhesive), By Application (Pain Relief), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10个工作天内

价格

经皮贴片市场趋势

2023年，全球经皮皮肤贴片市场预计将达到78.2亿美元，预计2024年至2030年复合年增长率为5.0%。心血管疾病、糖尿病和慢性疼痛等慢性疾病的盛行率不断上升，消费者对微创治疗的偏好不断提高，全球人口老化以及经皮给药系统的技术进步正在显着推动市场发展。

经皮皮肤贴片是传统口服和注射药物的非侵入性且方便的替代品。提高患者的依从性并尽量减少口服药物常见的胃肠道副作用。这种易用性和长时间稳定的药物释放使得经皮皮肤贴片对于慢性疾病的治疗特别有吸引力。

该市场正在经历显着成长，主要是由于全球慢性病的盛行率不断上升。根据美国疾病管制与预防中心 (CDC) 2024 年 2 月发布的报告，估计美国有 1.29 亿人患有至少一种主要慢性疾病，包括癌症、心臟病、肥胖、糖尿病和高血压。治疗慢性疼痛通常需要定期服用止痛药，但由于副作用和频繁给药，口服和注射药物可能很麻烦。

经皮皮肤贴片提供了一种解决方案，可以在较长时间内控制药物释放，提高患者的依从性并改善治疗结果。例如，用于治疗严重慢性疼痛的Fentanyl经皮皮肤贴片可提供连续 72 小时的药物剂量，减少了频繁给药的需要并维持稳定的疼痛缓解。

微针、离子电渗疗法和渗透促进剂等药物传递系统的创新大大扩展了经皮给药的范围，包括大分子和生技药品。微针贴片在皮肤上形成微小的凹槽，使得难以经皮给药的聚合物药物成为可能。一个显着的例子是用来注射胰岛素给糖尿病患者的微针贴片。这是日常注射的无痛治疗方法，可以改善血糖控制。另一项突破性技术是离子电渗透疗法，它利用微小的电荷来增加药物对皮肤的渗透。例如，IontoPatch 提供发炎剂来治疗肌腱炎和黏液囊炎等疾病，从而增加药物的吸收和有效性。这些进步提高了经皮系统的效率和可靠性，并引入了新的治疗可能性，推动了市场成长并扩大了可透过非侵入性手段治疗的疾病范围。

消费者对微创治疗的偏好不断增加是市场的主要驱动力。与口服药物或註射相比，患者和医疗保健提供者青睐这种贴片，因为它能缓解疼痛、降低感染风险，且副作用更少。例如，Biochemie Novartis 的 Estraderm Mx Patch 是一种荷尔蒙补充疗法贴剂，可稳定释放激素，从而最大限度地减少与口服 HRT 水平波动相关的副作用。此外，用于戒烟、疼痛管理和神经系统疾病的贴片描述了谨慎且方便的药物输送方法。这种非侵入性方法提高了患者的舒适度和依从性，随着人们对这些好处的认识的传播，推动了市场的成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章透皮经皮贴片市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 助剂市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业分析-波特五力分析
    • PESTEL分析

第四章透皮经皮贴片市场：类型、估计和趋势分析

  • 细分仪表板
  • 经皮皮肤贴片市场：类型变化分析，2023 年和 2030 年

第五章经皮贴片市场：应用、估计与趋势分析

  • 细分仪表板
  • 经皮皮肤贴片市场：2023 年和 2030 年应用变化分析

第六章透皮经皮贴片市场：通路、估计与趋势分析

  • 细分仪表板
  • 经皮贴片市场：2023 年与 2030 年通路变化分析

第七章经皮贴片市场：区域、估计与趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 2023年主要企业市场占有率分析
    • Teva Pharmaceutical Industries Ltd
    • Novartis AG
    • Teikoku Pharma USA Inc.
    • Viatris Inc.
    • Johnson &Johnson
    • Luye Pharma Group
    • Purdue Pharma Manufacturing LP
    • Henan Lingrui Pharmaceutical Ltd
    • Samyang Biopharmaceuticals Corp.
    • Hisamitsu Pharmaceutical Co, Inc.
Product Code: GVR-4-68040-361-1

Transdermal Skin Patches Market Trends

The global transdermal skin patches market was estimated at USD 7.82 billion in 2023 and is projected to grow at a CAGR of 5.0% from 2024 to 2030. The rising prevalence of chronic diseases such as cardiovascular disorders, diabetes, chronic pain, etc., increased consumer preference for minimally invasive treatment, the aging global population, and technological advancements in transdermal drug delivery systems have significantly boosted the market.

Transdermal patches provide a noninvasive, convenient alternative to traditional oral and injectable medications. They enhance patient compliance and minimize the gastrointestinal side effects that often accompany oral drugs. This ease of use and consistent drug release over extended periods make transdermal patches particularly attractive for managing chronic conditions.

The market is experiencing significant growth, primarily driven by the increasing prevalence of chronic diseases worldwide. According to the CDC report published in February 2024, an estimated 129 million people in the U.S. have at least 1 major chronic disease, such as cancer, heart disease, obesity, diabetes, and hypertension. Managing chronic pain typically involves regular administration of pain relief medication, which can be cumbersome with oral or injectable forms due to their side effects and the need for frequent dosing.

Transdermal patches offer a solution by providing a controlled release of medication over extended periods, which enhances patient compliance and improves therapeutic outcomes. For instance, the fentanyl transdermal patch, used for managing severe chronic pain, delivers the drug continuously for 72 hours, reducing the need for frequent dosing and maintaining steady pain relief.

Innovations in drug delivery systems, including microneedles, iontophoresis, and permeation enhancers, have significantly broadened the scope of transdermal medication delivery, accommodating large molecules and biologics. Microneedle patches create microscopic channels in the skin, enabling the administration of large molecule drugs that are otherwise difficult to deliver transdermal. A notable example is the microneedle patch for insulin delivery in diabetic patients, which offers a painless alternative to daily injections, potentially improving glycemic control. Iontophoresis, another breakthrough technology, employs a small electric charge to enhance drug penetration through the skin. For instance, IontoPatch delivers anti-inflammatory drugs to treat conditions like tendinitis and bursitis, increasing the drug's absorption and effectiveness. These advancements boost the efficiency and reliability of transdermal delivery systems and introduce new therapeutic possibilities, driving market growth and expanding the range of treatable conditions through non-invasive means.

The rising consumer preference for minimally invasive treatments significantly drives the market. Patients and healthcare providers favor these patches for reduced pain, lower infection risk, and fewer side effects than oral medications or injections. For instance, hormone replacement therapy patches Estraderm Mx Patch by Biochemie Novartis offer a steady hormone release, minimizing side effects linked to fluctuating levels seen with oral HRT. In addition, patches for smoking cessation, pain management, and neurological disorders provide a discreet and convenient drug delivery method. This non-invasive approach enhances patient comfort and compliance, boosting the market growth as awareness of these benefits spreads.

Global Transdermal Skin Patches Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global transdermal skin patches market based on type, application, distribution channel, and region:

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Matrix
  • Other Types
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Pain Relief
  • Smoking Reduction and Cessation Aid
  • Cardiovascular Disorders
  • Neurological Disorders
  • Hormonal Therapy
  • Other Applications
  • Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transdermal Skin Patches Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic and Social landscape
      • 3.2.4.3. Technological landscape

Chapter 4. Transdermal Skin Patches Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transdermal Skin Patches Market: Type Movement Analysis, 2023 & 2030 (USD Billion)
    • 4.2.1. Single-layer Drug-in-Adhesive
      • 4.2.1.1. Single-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.2.2. Multi-layer Drug-in-Adhesive
      • 4.2.2.1. Multi-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.2.3. Matrix
      • 4.2.3.1. Matrix Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.2.4. Other Types
      • 4.2.4.1. Other Types Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Transdermal Skin Patches Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transdermal Skin Patches Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
    • 5.2.1. Pain Relief
      • 5.2.1.1. Pain Relief Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.2. Smoking Reduction
      • 5.2.2.1. Smoking Reduction Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.3. Cardiovascular Disorders
      • 5.2.3.1. Cardiovascular Disorders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.4. Neurological Disorders
      • 5.2.4.1. Neurological Disorders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.5. Hormonal Therapy
      • 5.2.5.1. Hormonal Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.6. Other Applications
      • 5.2.6.1. Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Transdermal Skin Patches Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transdermal Skin Patches Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Billion)
    • 6.2.1. Hospital Pharmacies
      • 6.2.1.1. Hospital Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. Retail Pharmacies
      • 6.2.2.1. Retail Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.3. Online Pharmacies
      • 6.2.3.1. Online Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Transdermal Skin Patches Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2023
    • 8.3.2. Teva Pharmaceutical Industries Ltd
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Novartis AG
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Teikoku Pharma USA Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Viatris Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Johnson & Johnson
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Luye Pharma Group
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Purdue Pharma Manufacturing LP
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Henan Lingrui Pharmaceutical Ltd
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Samyang Biopharmaceuticals Corp.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Hisamitsu Pharmaceutical Co, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Transdermal Skin Patches Market, By Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 6 Global Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 7 Global Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 8 North America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 9 North America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 10 North America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 11 North America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 12 U.S. Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S. Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 14 U.S. Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15 Canada Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 17 Canada Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 18 Mexico Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 19 Mexico Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 20 Mexico Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 21 Europe Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 22 Europe Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 23 Europe Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 24 Europe Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 25 UK Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 26 UK Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 27 UK Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 Germany Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 29 Germany Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 30 Germany Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 31 France Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 32 France Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 33 France Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34 Italy Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 35 Italy Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 36 Italy Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 37 Spain Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 38 Spain Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 39 Spain Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Denmark Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 41 Denmark Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 42 Denmark Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 43 Sweden Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 44 Sweden Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 45 Sweden Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46 Norway Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 47 Norway Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 48 Norway Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 49 Asia Pacific Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 53 Japan Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 54 Japan Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 55 Japan Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 56 China Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 57 China Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 58 China Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 59 India Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 60 India Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 61 India Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 62 South Korea Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 63 South Korea Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 64 South Korea Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65 Australia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 66 Australia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 67 Australia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 68 Thailand Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 69 Thailand Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 70 Thailand Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 71 Latin America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 72 Latin America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 73 Latin America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 74 Latin America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 75 Brazil Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 76 Brazil Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 77 Brazil Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 78 Argentina Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 79 Argentina Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 80 Argentina Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81 Middle East and Africa Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 82 Middle East and Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 83 Middle East and Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 84 Middle East & Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 85 South Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 86 South Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 87 South Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 90 Saudi Arabia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 91 UAE Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 92 UAE Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 93 UAE Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 96 Kuwait Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Transdermal Skin Patches market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Transdermal Skin Patches market: Type movement analysis
  • Fig. 17 Transdermal Skin Patches market: Type segment dashboard
  • Fig. 18 Transdermal Skin Patches market Type outlook: Key takeaways
  • Fig. 19 Single-layer Drug-in-Adhesive Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Multi-layer Drug-in-AdhesiveTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 MatrixTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Other TypesTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Transdermal Skin Patches market: Application movement analysis
  • Fig. 24 Transdermal Skin Patches market Application outlook: Key takeaways
  • Fig. 25 Pain Relief Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Smoking Reduction and Cessation Aid Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Cardiovascular Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Neurological Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Hormonal Therapy Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Other Applications Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Transdermal Skin Patches market: Distribution Channel movement analysis
  • Fig. 32 Transdermal Skin Patches market Distribution Channel outlook: Key takeaways
  • Fig. 33 Hospital Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Retail Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Online Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Regional outlook, 2023 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 North America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 43 UK Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Spain Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 46 France Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 47 Italy implantable Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Denmark Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 49 Sweden Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Norway Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 51 Asia Pacific Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 52 Japan Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 53 China Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 54 India Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 55 South Korea Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 56 Australia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 57 Thailand Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 58 Latin America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 59 Brazil Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 62 MEA Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 63 South Africa Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 64 Saudi Arabia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 67 Heat map analysis
  • Fig. 68 Market differentiators